Rankweil

Vetter: Service Provider Further Expands Offerings for Clinical Development and Manufacturing

Retrieved on: 
Tuesday, May 9, 2023
Biotechnology, Health, Science, Other Science, Pharmaceutical, Running, CDMO, Senior, Multimedia, Fine chemical, Rankweil

By the end of 2021, Vetter’s production in Rankweil was up and running, and 17 customer projects have already been won.

Key Points: 
  • By the end of 2021, Vetter’s production in Rankweil was up and running, and 17 customer projects have already been won.
  • View the full release here: https://www.businesswire.com/news/home/20230509005833/en/
    Vetter continues to drive the expansion of capacities and services for the provision of clinical trial materials at its Austrian site.
  • Furthermore, the pharmaceutical service provider has doubled the capacity for cold storage by purchasing additional freezers.
  • Vetter is also expanding its customer-oriented service offering – with the implementation of an isolator, powdered substances can now also be processed in Rankweil.

Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills

Retrieved on: 
Tuesday, June 28, 2022
Biotechnology, Pharmaceutical, Health, Biotechnology, CGMP, New business development, AGES, Syringe, CDMO, Compliance, Contract, Social responsibility, Solution, Drug development, Multimedia, Fine chemical, Rankweil

With the realization of the first successful customer fills, Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.

Key Points: 
  • With the realization of the first successful customer fills, Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.
  • Within one year of its purchase, the site was adapted and integrated to meet Vetters high quality standards.
  • We have been highly focused on achieving the strategic integration of the site, said Dr. Martin Schwab, Site Head Austria.
  • Vetter services range from early stage development support including clinical manufacturing , to commercial supply and numerous packaging solutions for vials, syringes and cartridges.

Vetter’s New Clinical Manufacturing Site Now Officially Authorized

Retrieved on: 
Wednesday, January 19, 2022
Health, Manufacturing, Research, Other Manufacturing, Science, Pharmaceutical, Biotechnology, Patient, Biotechnology, CDMO, Social responsibility, Contract, Quality assurance, GMP, Quality control, CGMP, Multimedia, AGES, Compliance, II, Senior, Patient safety, Syringe, Pharmaceutical industry, Fine chemical, Rankweil, Vetter

Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria.

Key Points: 
  • Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria.
  • View the full release here: https://www.businesswire.com/news/home/20220119005682/en/
    Manufacturing of prefilled vial systems at Vetter (Photo: Business Wire)
    Vetter Development Service Rankweil represents the companys European counterpart to its existing clinical manufacturing site near Chicago.
  • With the new site further expanding its international presence , Vetter is responding to the growing global demand for fill & finish services.
  • The successfully completed cGMP inspection by AGES enables the new clinical manufacturing facility in Rankweil to officially start operations and to realize customer projects in the clinical development phase on their way to approval.

Vetter further expands its Development Service with new site in Austria

Retrieved on: 
Wednesday, July 8, 2020
Biotechnology, Health, Pharmaceutical, Commercial Building & Real Estate, Construction & Property, Rankweil, Contract manufacturing organization, Vetter, Vetter Pharma

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.

Key Points: 
  • Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.
  • View the full release here: https://www.businesswire.com/news/home/20200708005638/en/
    With the new Vetter Development Service Rankweil site in Austria, Vetter expands its European footprint.
  • The new site expands our European footprint and can be seen as counterpart to our existing US clinical manufacturing site near Chicago.
  • Vetter Development Service Rankweil (VDS-R) plans call for the start of operations in the second half of 2021.